Robert Tressler
Profile
Robert Tressler worked as an Executive Director of Preclinical Research at Geron Corp., an Associate Director of Pharmacology at CHIRON Biopharmaceuticals, a Senior Director of Pharmacology at Matrix Pharmaceuticals, a Principal at Ligand Pharmaceuticals, a Vice President of Research and Development at Cellerant Therapeutics, and a Principal at Syntex, Inc. He holds a doctorate degree from The University of Texas at Austin and a graduate degree from McNeese State University.
Former positions of Robert Tressler
| Companies | Position | End |
|---|---|---|
| CHIRON Biopharmaceuticals | Corporate Officer/Principal | - |
| LIGAND PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | - |
| Syntex, Inc. | Corporate Officer/Principal | - |
| Matrix Pharmaceuticals, Inc. | Corporate Officer/Principal | - |
| GERON CORPORATION | Corporate Officer/Principal | - |
Training of Robert Tressler
| The University of Texas at Austin | Doctorate Degree |
| McNeese State University | Graduate Degree |
Experiences
Positions held
Linked companies
| Listed companies | 2 |
|---|---|
| LIGAND PHARMACEUTICALS INCORPORATED | Health Technology |
| GERON CORPORATION | Health Technology |
| Private companies | 4 |
|---|---|
Cellerant Therapeutics, Inc.
 Cellerant Therapeutics, Inc. Medical SpecialtiesHealth Technology Cellerant Therapeutics, Inc. develops stem cell-based cellular and antibody therapeutics for blood disorders and cancer. The firm focuses on curative therapies for seriously ill patients and is developing a cell-based medicine as a treatment for chemotherapy and radiation-induced neutropenia as well as for Acute Radiation Syndrome. The company was founded by Irving L. Weissman in 2003 and is headquartered in San Carlos, CA. | Health Technology |
| CHIRON Biopharmaceuticals | |
| Syntex, Inc. | Miscellaneous |
| Matrix Pharmaceuticals, Inc. |
- Stock Market
- Insiders
- Robert Tressler
